Human Mixtard 30/70 40IU Injection 1X10ml
₹182.39
* Mkt: Abbott India Ltd * Country of Origin: India * Delivery charges if applicable will be applied at checkout
Out of stock
INTRODUCTION ABOUT HUMAN MIXTARD 30/70 40IU INJECTION
HUMAN MIXTARD 30/70 40IU INJECTION contains Biphasic Isophane Insulin which
belongs to the group of medicines called Antidiabetic agents. It
improves glycemic control in patients with diabetes mellitus (both type I
and type II).
Biphasic Isophane Insulin is a pre-mixed
combination of Regular (soluble) insulin and Isophane (NPH) insulin. It
is a fast-acting medicine where it begins to lower blood sugar levels
within 30 minutes. Therefore, inject the medicine 30 minutes before meal
and make sure to have your meals within the next 30 minutes.
Talk
to your doctor before starting therapy with HUMAN MIXTARD 30/70 40IU
INJECTION if you have any liver, kidney or heart problems. You must also
inform your doctor if you have any hormonal problems, made sudden
changes to your diet or perform intense exercise as a precaution. Do not
use this medicine if you have hypoglycemia (low blood sugar levels).
Consult your doctor before using this medicine if you are pregnant or
breastfeeding.
The most common side effects of receiving HUMAN
MIXTARD 30/70 40IU INJECTION are low blood sugar levels, pain, redness,
itching, swelling or thickening at the injection site, lump formation
under the skin and swelling of body parts. Consult your doctor if any of
these side effect troubles you.
USES OF HUMAN MIXTARD 30/70 40IU INJECTION
- Improves glycemic control in patients with diabetes mellitus (both type I and type II)
HOW HUMAN MIXTARD 30/70 40IU INJECTION WORKS
HUMAN
MIXTARD 30/70 40IU INJECTION helps your body to make utilize of the
circulating blood glucose. It helps in the transport of glucose from the
blood into the muscles and fat tissues. It also stops the production of
glucose by the liver. As a result, it controls blood sugar levels and
improve glycemic control in patients with diabetes mellitus.
DIRECTIONS FOR USE
Use
HUMAN MIXTARD 30/70 40IU INJECTION under careful medical supervision.
Inject HUMAN MIXTARD 30/70 40IU INJECTION into your thighs, buttocks,
upper arm, or abdomen (i.e., subcutaneously). Do not administer this
medicine into the vein or muscle directly. It should be administered at
least 10 minutes before meals. Eat a meal or snack containing
carbohydrates within 20 minutes of the injection to avoid low blood
sugar.
Before administration, roll the vial/cartridge between
your hands until the liquid becomes uniformly white and cloudy. While
injecting, keep the needle under the skin for at least 6 seconds to make
sure that the entire dose is injected.
Prior to the
administration, visualize the cartridge/vial for any visible particulate
matter and discoloration. Discard the needle and syringe after use and
do not share your needles with others to avoid the risk of transmission
of infections.
Avoid repeatedly injecting the medicine at the
same site to manage skin damage. Instead, rotate the injection site.
Make sure to consult your doctor before changing the injection site as a
precaution.
HUMAN MIXTARD 30/70 40IU INJECTION should not be
mixed with any other insulins before use. Do not stop therapy with HUMAN
MIXTARD 30/70 40IU INJECTION without consulting your doctor. Your
doctor will decide correct dose and frequency of administration
depending upon your age, body weight and health condition.
SIDE EFFECTS OF HUMAN MIXTARD 30/70 40IU INJECTION
COMMON
- Injection site reactions (such as pain, redness, itching or swelling)
- Lipodystrophy (shrinkage of fat tissues beneath the skin)
- Lumps under the skin
- Weight gain, swelling of body parts
- Hypoglycemia (Low blood sugar levels)
UNCOMMON
- Diabetic retinopathy (eye diseases due to diabetes)
- Swelling around the ankles and other joints
- Painful neuropathy (pain caused by nerve damage)
RARE
- Problem in vision
Consult your doctor immediately if you experience any of the following side effects:
- Allergic
reaction (generalized skin rash with itching, sweating, and swelling of
layers under the skin, difficulties in breathing, palpitation,
vomiting, stomach upset, reduction in blood pressure and fainting /loss
of consciousness) - Signs of severe hypoglycemia (such as cold
sweats, cool pale skin, headache, rapid heartbeat, nausea, increased
hunger, temporary vision changes, drowsiness, tiredness and weakness,
nervousness or tremor, anxiety, confusion and difficulty in
concentrating)
HOW TO MANAGE SIDE EFFECTS
Hypoglycemia
Managing
hypoglycemia, or low blood sugar, involves prompt action to raise blood
glucose levels and manage complications. When experiencing
hypoglycemia, individuals should quickly consume a source of
rapidly-absorbed carbohydrates, such as glucose tablets, fruit juice, or
regular soda. Waiting for about 15 minutes and rechecking blood sugar
levels is crucial to ensure they rise to a safe range. If hypoglycemia
persists, additional carbohydrate intake may be necessary. Once blood
sugar levels stabilize, a small snack containing both carbohydrates and
protein can help sustain them. Regular monitoring and consultation with a
healthcare professional are essential for developing a personalized
plan to manage hypoglycemia effectively. In severe cases, emergency
assistance may be required.
Injection Site Reactions
Managing
injection site reactions is essential for individuals who regularly
administer injections. To alleviate discomfort and minimize potential
issues, it is crucial to follow proper injection techniques. Rotate
injection sites to manage overuse of a single area, allowing tissues to
heal. Use a clean, sterile needle and syringe for each injection. Apply
an ice pack to the injection site before and after administration to
reduce pain and swelling. If redness, swelling, or irritation persists,
consult a healthcare professional for guidance. It is essential to
report any severe or persistent reactions to ensure appropriate
adjustments to the injection routine and to manage potential
complications.
WARNING & PRECAUTIONS
PREGNANCY
Consult your doctor
HUMAN
MIXTARD 30/70 40IU INJECTION can be used during pregnancy only if
considered necessary by the physician. Therefore, consult your doctor
before administration.
BREASTFEEDING
Safe
HUMAN
MIXTARD 30/70 40IU INJECTION is considered safe for use during
breastfeeding. However, consult your doctor before administration.
DRIVING AND USING MACHINES
Use with Caution
As,
HUMAN MIXTARD 30/70 40IU INJECTION can cause hypoglycemia, it may
affect your ability to concentrate and focus. Therefore, be cautious to
avoid the risk of hypoglycemia while driving or handling heavy machines.
ALCOHOL
Contraindicated
Avoid consumption of alcohol while taking this medicine as it could aggravate your existing disease condition.
KIDNEY
Use with Caution
HUMAN
MIXTARD 30/70 40IU INJECTION should be used with caution in patients
with kidney problems. Therefore, consult your doctor before
administration.
LIVER
Use with Caution
HUMAN
MIXTARD 30/70 40IU INJECTION should be used with caution in patients
with liver problems. Therefore, consult your doctor before
administration.
ALLERGY
Contraindicated
Talk
to your doctor before receiving HUMAN MIXTARD 30/70 40IU INJECTION if
you are allergic to Regular insulin, Isophane insulin or to any other
Human insulin (Ex. Lente, ultra-Lente).
HEART DISEASE
Use with Caution
HUMAN
MIXTARD 30/70 40IU INJECTION should be taken with caution in patients
with heart disease. Therefore, consult your doctor before
administration.
USE IN PEDIATRICS
Consult your doctor
HUMAN
MIXTARD 30/70 40IU INJECTION can be used in children and adolescents
(aged below 18 years) if prescribed by the physician. Therefore, consult
your doctor before administration.
USE IN GERIATRICS
Monitoring required
HUMAN
MIXTARD 30/70 40IU INJECTION should be used with caution in elderly
patients (aged 65 years or above). Therefore, consult your doctor before
administration. Proper dose adjustments and careful monitoring of blood
glucose levels and kidney functions are required in such patients.
OTHERS
HUMAN MIXTARD 30/70 40IU INJECTION is not recommended for use if you:
- Have or at risk of developing hypoglycemia (low blood sugar levels)
Talk to your doctor before receiving HUMAN MIXTARD 30/70 40IU INJECTION if you:
- Have problems in adrenal, pituitary or thyroid glands
- Have recently changed your diet plan and lifestyle
- Are exercising more than usual
- Recently became ill or had any infections
- Are planning to go abroad (as mealtime and injection timings may get changed)
| Weight | 20 g |
|---|
General Inquiries
There are no inquiries yet.
Related products
Customer reviews
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.